FDA Approves Cytokinetics' MYQORZO For Treatment Of Obstructive Hypertrophic Cardiomyopathy
(RTTNews) - Cytokinetics, Inc. (CYTK) announced that the U.S. Food and Drug Administration has approved MYQORZO (aficamten) tablets in 5 mg, 10 m...
20 Dec 03:03 · finanzen.at